<DOC>
	<DOCNO>NCT01234597</DOCNO>
	<brief_summary>Primary Objective : To evaluate effect prandial treatment adjustment , base continuous blood glucose monitoring , glucose control type 2 diabetes patient control treatment daily basal insulin mixed insulin , require treatment basal plus regimen</brief_summary>
	<brief_title>Evaluation Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring Type 2 Diabetes Mellitus ( DM ) Patients Uncontrolled With Basal Insulin Premix Once Day</brief_title>
	<detailed_description>The study duration patient 24 week +/- 1 week break follow : - Run-in phase : 8 week - Follow - Period : 16 week The maximal possible time window study +/- one week throughout study .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Inclusion criterion : Runin period : 1 . Type 2 diabetes 2 . HbA1câ‰¥ 8.5 % ( test last month ) 3 . Age 21 year 4 . Patients continuously treat basal insulin mixed insulin daily last 6 month 5 . Signed informed consent form 6 . Patients accord physician eligible study Randomization : 1 . HbA1c &gt; 7.5 % 2 . FPG &lt; 130 mg/dl Exclusion criterion : 1 . Type 1 diabetes 2 . Patients continuously treat shortacting insulin mixed insulin daily 3 week last 6 month . 3 . Pregnant breastfeed woman . 4 . Patients allergy insulin . 5 . Patients severe disease characterize recurrent hospitalization , include : Severe renal insufficiency , severe cardiac insufficiency , active oncological disease oncological disease require chemotherapy . 6 . Patients mobility difficulty and/or difficulty communicate investigator The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>